Moret-Tatay et al. in 2019 identified an epigenetic methylation signature (methylation status of the DEFA5 and TNF genes as a characteristic biomarker) to characterize CD patients and support the likely influence of the environment and immune system on CD pathogenesis [164]. The gene discussed is TNF; the disease is Cowden disease.